SICHUAN HEBANG BIOTECHNOLOGY CORPORATION LIMITED Financials Sichuan Hebang Biotechnology Corporation Limited
Equities
603077
CNE100001JM9
Agricultural Chemicals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.06 CNY | +0.49% |
|
-2.83% | -12.71% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 14,307 | 12,737 | 12,117 | 28,624 | 26,524 | 20,591 |
| Enterprise Value (EV) 1 | 14,093 | 13,795 | 13,415 | 28,228 | 23,751 | 19,496 |
| P/E ratio | 40.5 x | 24.7 x | 296 x | 9.51 x | 6.95 x | 16 x |
| Yield | - | - | - | 0.44% | 1.48% | - |
| Capitalization / Revenue | 2.38 x | 2.13 x | 2.3 x | 2.9 x | 2.03 x | 2.33 x |
| EV / Revenue | 2.35 x | 2.31 x | 2.55 x | 2.86 x | 1.82 x | 2.21 x |
| EV / EBITDA | 11.9 x | 10.8 x | 11.5 x | 6.6 x | 4.4 x | 8.09 x |
| EV / FCF | 12.1 x | 409 x | 12.6 x | 21.3 x | 15.7 x | -25.2 x |
| FCF Yield | 8.24% | 0.24% | 7.91% | 4.69% | 6.36% | -3.97% |
| Price to Book | 1.3 x | 1.13 x | 1.09 x | 2.01 x | 1.39 x | 1.03 x |
| Nbr of stocks (in thousands) | 8,831,250 | 8,606,301 | 8,533,357 | 8,394,127 | 8,725,163 | 8,725,163 |
| Reference price 2 | 1.620 | 1.480 | 1.420 | 3.410 | 3.040 | 2.360 |
| Announcement Date | 4/24/19 | 4/21/20 | 4/26/21 | 3/14/22 | 2/20/23 | 4/19/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 6,009 | 5,969 | 5,261 | 9,867 | 13,039 | 8,824 |
| EBITDA 1 | 1,183 | 1,279 | 1,165 | 4,279 | 5,400 | 2,410 |
| EBIT 1 | 608.3 | 643.2 | 522.5 | 3,648 | 4,486 | 1,422 |
| Operating Margin | 10.12% | 10.78% | 9.93% | 36.98% | 34.4% | 16.11% |
| Earnings before Tax (EBT) 1 | 415.7 | 583.8 | 15.81 | 3,583 | 4,479 | 1,536 |
| Net income 1 | 363.1 | 516.9 | 40.94 | 3,023 | 3,807 | 1,283 |
| Net margin | 6.04% | 8.66% | 0.78% | 30.64% | 29.2% | 14.54% |
| EPS 2 | 0.0400 | 0.0600 | 0.004800 | 0.3584 | 0.4377 | 0.1474 |
| Free Cash Flow 1 | 1,161 | 33.75 | 1,062 | 1,324 | 1,510 | -773.5 |
| FCF margin | 19.33% | 0.57% | 20.18% | 13.42% | 11.58% | -8.77% |
| FCF Conversion (EBITDA) | 98.14% | 2.64% | 91.08% | 30.93% | 27.96% | - |
| FCF Conversion (Net income) | 319.86% | 6.53% | 2,592.73% | 43.79% | 39.66% | - |
| Dividend per Share | - | - | - | 0.0150 | 0.0450 | - |
| Announcement Date | 4/24/19 | 4/21/20 | 4/26/21 | 3/14/22 | 2/20/23 | 4/19/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | 1,058 | 1,298 | - | - | - |
| Net Cash position 1 | 214 | - | - | 396 | 2,773 | 1,096 |
| Leverage (Debt/EBITDA) | - | 0.8275 x | 1.113 x | - | - | - |
| Free Cash Flow 1 | 1,161 | 33.8 | 1,062 | 1,324 | 1,510 | -773 |
| ROE (net income / shareholders' equity) | 2.65% | 4.47% | 0.03% | 23.4% | 22.2% | 6.4% |
| ROA (Net income/ Total Assets) | 2.88% | 2.9% | 2.24% | 14% | 13.3% | 3.65% |
| Assets 1 | 12,605 | 17,852 | 1,832 | 21,653 | 28,533 | 35,128 |
| Book Value Per Share 2 | 1.240 | 1.310 | 1.310 | 1.700 | 2.190 | 2.300 |
| Cash Flow per Share 2 | 0.1500 | 0.0700 | 0.1000 | 0.2000 | 0.5300 | 0.3600 |
| Capex 1 | 364 | 663 | 197 | 1,735 | 936 | 829 |
| Capex / Sales | 6.05% | 11.1% | 3.75% | 17.58% | 7.18% | 9.39% |
| Announcement Date | 4/24/19 | 4/21/20 | 4/26/21 | 3/14/22 | 2/20/23 | 4/19/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -12.71% | 2.36B | |
| +17.80% | 39.34B | |
| -.--% | 11.28B | |
| +1.48% | 7.99B | |
| +1.79% | 6.51B | |
| -2.15% | 6.18B | |
| +36.99% | 5.43B | |
| -13.59% | 5.37B | |
| -13.00% | 4.61B | |
| +4.12% | 3.89B |
- Stock Market
- Equities
- 603077 Stock
- Financials Sichuan Hebang Biotechnology Corporation Limited
